These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Latest evidence on the management of early-stage and locally advanced rectal cancer: a narrative review. Prabhakaran S; Yang TWW; Johnson N; Bell S; Chin M; Simpson P; Carne P; Farmer C; Skinner S; Warrier SK; Kong JC ANZ J Surg; 2022 Mar; 92(3):365-372. PubMed ID: 35001464 [TBL] [Abstract][Full Text] [Related]
3. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE). Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356 [TBL] [Abstract][Full Text] [Related]
4. A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Li Y; Wang J; Ma X; Tan L; Yan Y; Xue C; Hui B; Liu R; Ma H; Ren J Int J Biol Sci; 2016; 12(8):1022-31. PubMed ID: 27489505 [TBL] [Abstract][Full Text] [Related]
5. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors]. Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549 [No Abstract] [Full Text] [Related]
7. Current status of locally advanced rectal cancer therapy and future prospects. Koukourakis IM; Kouloulias V; Tiniakos D; Georgakopoulos I; Zygogianni A Crit Rev Oncol Hematol; 2023 Jun; 186():103992. PubMed ID: 37059276 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of total neoadjuvant therapy versus neoadjuvant chemoradiotherapy in the treatment of locally advanced rectal cancer: a meta-analysis]. Zhang YQ; Sun KG; Lu JY; Ma J; Yao N; Qin ZH; Yao YH Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):531-538. PubMed ID: 35754218 [No Abstract] [Full Text] [Related]
9. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial. Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919 [TBL] [Abstract][Full Text] [Related]
10. [Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer]. Fan J; Zhu J Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):527-533. PubMed ID: 31238633 [TBL] [Abstract][Full Text] [Related]
11. The Impact of Chemotherapy Completion on the Efficacy of Irinotecan in the Preoperative Chemoradiotherapy of Locally Advanced Rectal Cancer: An Expanded Analysis of the CinClare Phase III Trial. Wang J; Fan J; Li C; Yang L; Wan J; Zhang H; Zhang Z; Zhu J Clin Colorectal Cancer; 2020 Jun; 19(2):e58-e69. PubMed ID: 32265117 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer. Sada YH; Tran Cao HS; Chang GJ; Artinyan A; Musher BL; Smaglo BG; Massarweh NN J Surg Res; 2018 Jun; 226():15-23. PubMed ID: 29661280 [TBL] [Abstract][Full Text] [Related]
14. Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all! Ozer L; Yildiz I; Bayoglu V; Bozkurt M; Esen E; Remzi FH; Gogenur I; Aytac E Colorectal Dis; 2021 Jul; 23(7):1662-1669. PubMed ID: 33829626 [TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358 [TBL] [Abstract][Full Text] [Related]
17. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis. Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant radiotherapy for rectal cancer management. Feeney G; Sehgal R; Sheehan M; Hogan A; Regan M; Joyce M; Kerin M World J Gastroenterol; 2019 Sep; 25(33):4850-4869. PubMed ID: 31543678 [TBL] [Abstract][Full Text] [Related]
19. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J; BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study. Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]